BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8508412)

  • 1. bcl-2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features.
    Jacobson JO; Wilkes BM; Kwaiatkowski DJ; Medeiros LJ; Aisenberg AC; Harris NL
    Cancer; 1993 Jul; 72(1):231-6. PubMed ID: 8508412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas.
    Kawasaki C; Ohshim K; Suzumiya J; Kanda M; Tsuchiya T; Tamura K; Kikuchi M
    Leuk Lymphoma; 2001; 42(5):1099-106. PubMed ID: 11697627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of Bcl 10 rearrangement in diffuse large B-cell lymphoma.
    Kawasaki C; Ohshima K; Muta H; Muta K; Deyev V; Podack ER; Kikuchi M
    Leuk Lymphoma; 2002 Apr; 43(4):823-6. PubMed ID: 12153171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
    Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffuse large B-cell lymphoma with primary retroperitoneal presentation: clinico-pathologic study of nine cases.
    Pileri SA; Zinzani PL; Ascani S; Orcioni GF; Gamberi B; Piccioli M; Sabattini E; Poggi S; Piccaluga PP; Falini B
    Ann Oncol; 2001 Oct; 12(10):1445-53. PubMed ID: 11762818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of primary mediastinal B cell lymphoma.
    Tsang P; Cesarman E; Chadburn A; Liu YF; Knowles DM
    Am J Pathol; 1996 Jun; 148(6):2017-25. PubMed ID: 8669486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas.
    Pescarmona E; De Sanctis V; Pistilli A; Pacchiarotti A; Martelli M; Guglielmi C; Mandelli F; Baroni CD; Le Coco F
    J Pathol; 1997 Nov; 183(3):281-6. PubMed ID: 9422982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
    Huebner-Chan D; Fernandes B; Yang G; Lim MS
    Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma.
    Raghoebier S; Kramer MH; van Krieken JH; de Jong D; Limpens J; Kluin-Nelemans JC; van Ommen GJ; Kluin PM
    Blood; 1991 Nov; 78(10):2680-5. PubMed ID: 1824261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients.
    Vitolo U; Gaidano G; Botto B; Volpe G; Audisio E; Bertini M; Calvi R; Freilone R; Novero D; Orsucci L; Pastore C; Capello D; Parvis G; Sacco C; Zagonel V; Carbone A; Mazza U; Palestro G; Saglio G; Resegotti L
    Ann Oncol; 1998 Jan; 9(1):55-61. PubMed ID: 9541684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of bcl-6 protein expression and gene rearrangement in diffuse large B-cell lymphoma].
    Min DL; Xia HL; Zhou XY; Sun MH; Yang WT; Zhang TM; Zheng AH; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):327-31. PubMed ID: 16185497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes.
    Goodlad JR; Krajewski AS; Batstone PJ; McKay P; White JM; Benton EC; Kavanagh GM; Lucraft HH;
    Am J Surg Pathol; 2003 Dec; 27(12):1538-45. PubMed ID: 14657713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of BCL-6 gene rearrangement in diffuse large B-cell lymphoma of primary gastric origin.
    Liang R; Chan WP; Kwong YL; Xu WS; Srivastava G; Ho FC
    Cancer Genet Cytogenet; 1997 Sep; 97(2):114-8. PubMed ID: 9283593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
    Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
    Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome.
    Tibiletti MG; Martin V; Bernasconi B; Del Curto B; Pecciarini L; Uccella S; Pruneri G; Ponzoni M; Mazzucchelli L; Martinelli G; Ferreri AJ; Pinotti G; Assanelli A; Scandurra M; Doglioni C; Zucca E; Capella C; Bertoni F
    Hum Pathol; 2009 May; 40(5):645-52. PubMed ID: 19144384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study.
    Jerkeman M; Aman P; Cavallin-Stahl E; Torlakovic E; Akerman M; Mitelman F; Fioretos T
    Int J Oncol; 2002 Jan; 20(1):161-5. PubMed ID: 11743658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.
    Zinzani PL; Dirnhofer S; Sabattini E; Alinari L; Piccaluga PP; Stefoni V; Tani M; Musuraca G; Marchi E; Falini B; Baccarani M; Pileri SA
    Haematologica; 2005 Mar; 90(3):341-7. PubMed ID: 15749666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of bcl-2 (MBR)/JH rearrangement in the peripheral blood of patients with diffuse large B-cell lymphomas.
    Zucca E; Bertoni F; Bosshard G; Roggero E; Ceresa E; Sanna P; Pedrinis E; Cavalli F
    Ann Oncol; 1996 Dec; 7(10):1023-7. PubMed ID: 9037360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.